BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35705024)

  • 21. Influence of Intensity-Modulated Radiation Therapy on the Life Quality of Patients with Nasopharyngeal Carcinoma.
    Chen J; Liu P; Wang Q; Wu L; Zhang X
    Cell Biochem Biophys; 2015 Dec; 73(3):731-6. PubMed ID: 27259317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Locoregional control after intensity-modulated radiotherapy for nasopharyngeal carcinoma with an anatomy-based target definition.
    Kawashima M; Ariji T; Kameoka S; Ueda T; Kohno R; Nishio T; Arahira S; Motegi A; Zenda S; Akimoto T; Tahara M; Hayashi R
    Jpn J Clin Oncol; 2013 Dec; 43(12):1218-25. PubMed ID: 24072854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term late toxicities and quality of life for survivors of nasopharyngeal carcinoma treated with intensity-modulated radiotherapy versus non-intensity-modulated radiotherapy.
    Huang TL; Chien CY; Tsai WL; Liao KC; Chou SY; Lin HC; Dean Luo S; Lee TF; Lee CH; Fang FM
    Head Neck; 2016 Apr; 38 Suppl 1():E1026-32. PubMed ID: 26041548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical observation of 73 nasopharyngeal carcinoma patients treated by helical tomotherapy: the China experience.
    Ren G; Du L; Ma L; Feng LC; Zhou GX; Qu BL; Xu SP; Xie CB; Ou GM; Li F; Zhang XX; Yang J
    Technol Cancer Res Treat; 2011 Jun; 10(3):259-66. PubMed ID: 21517132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
    Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life and survival outcome for patients with nasopharyngeal carcinoma treated by volumetric-modulated arc therapy versus intensity-modulated radiotherapy.
    Huang TL; Tsai MH; Chuang HC; Chien CY; Lin YT; Tsai WL; Fang FM
    Radiat Oncol; 2020 Apr; 15(1):84. PubMed ID: 32307024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term Survivals, Toxicities and the Role of Chemotherapy in Early-Stage Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy: A Retrospective Study with 15-Year Follow-up.
    Wang L; Miao J; Huang H; Chen B; Xiao X; Zhu M; Liang Y; Xiao W; Huang S; Peng Y; Deng X; Lv X; Xia W; Xiang Y; Guo X; Han F; Zhao C
    Cancer Res Treat; 2022 Jan; 54(1):118-129. PubMed ID: 34098625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: treatment outcomes of a prospective, multicentric clinical study.
    Wu F; Wang R; Lu H; Wei B; Feng G; Li G; Liu M; Yan H; Zhu J; Zhang Y; Hu K
    Radiother Oncol; 2014 Jul; 112(1):106-11. PubMed ID: 24933452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-treatment late complications of nasopharyngeal carcinoma.
    Lee CC; Ho CY
    Eur Arch Otorhinolaryngol; 2012 Nov; 269(11):2401-9. PubMed ID: 22249834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. IMRT improves local control in patients with nasopharyngeal carcinoma compared with conventional radiotherapy: propensity score-matched analysis.
    Ma Z; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Takeda K; Suzuki Y; Tang L; Ito K; Kadoya N; Jingu K
    Jpn J Clin Oncol; 2021 Aug; 51(9):1444-1451. PubMed ID: 34250545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: the University of California-San Francisco experience.
    Sultanem K; Shu HK; Xia P; Akazawa C; Quivey JM; Verhey LJ; Fu KK
    Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):711-22. PubMed ID: 11020568
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Risk factors of level Ib lymphadenopathy in nasopharyngeal carcinoma].
    Yuan G; Zheng X; Zhu X; Wang Z; Song W; Zhang H; Sha Z
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):983-7. PubMed ID: 25057069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy.
    Wang L; Wu Z; He Q; Li Y; Wang S; Li F; Wang H; Li W; Han Y
    Cancer Med; 2024 Feb; 13(3):e6723. PubMed ID: 38156901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical treatment considerations in the intensity-modulated radiotherapy era for patients with N0-category nasopharyngeal carcinoma and enlarged neck lymph nodes.
    Peng H; Chen L; Guo R; Zhang Y; Li WF; Mao YP; Sun Y; Zhang F; Liu LZ; Tian L; Ma J
    Chin J Cancer; 2017 Mar; 36(1):32. PubMed ID: 28340596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship Between the Comprehensive Nutritional Index and the EORTC QLQ-H&N35 in Nasopharyngeal Carcinoma Patients Treated with Intensity-Modulated Radiation Therapy.
    He Y; Chen L; Chen L; Hu W; Wang C; Tang L; Mai H; Li J; Wu L; Fan Y
    Nutr Cancer; 2017 Apr; 69(3):436-443. PubMed ID: 28287323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
    Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
    BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial.
    Pow EH; Kwong DL; McMillan AS; Wong MC; Sham JS; Leung LH; Leung WK
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):981-91. PubMed ID: 17145528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.
    Du L; Zhang XX; Feng LC; Qu BL; Chen J; Yang J; Liu HX; Xu SP; Xie CB; Ma L
    BMC Cancer; 2017 Aug; 17(1):582. PubMed ID: 28851315
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience.
    Kam MK; Teo PM; Chau RM; Cheung KY; Choi PH; Kwan WH; Leung SF; Zee B; Chan AT
    Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1440-50. PubMed ID: 15590175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.